1. Central

Terminal cancer sufferer condemns withdrawal of drug

A terminal cancer sufferer from Derbyshire has condemned the decision by the NHS drugs watchdog to withdraw the use of the drug Kadcyla to fight the disease on the grounds of cost.

The drug, which can add months to the life of women dying of breast cancer, costs £90,000 for a course of treatment.

The National Institute for Health and Care Excellence (Nice) said the drug was too expensive to recommend for widespread use in the health service.

View all 5 updates ›

Terminal cancer sufferer condemns withdrawal of drug

A terminal cancer sufferer from Derbyshire has condemned the decision by the NHS drugs watchdog to withdraw the use of the drug Kadcyla to fight the disease on the grounds of cost.

The drug, which can add months to the life of women dying of breast cancer, costs £90,000 for a course of treatment.

The National Institute for Health and Care Excellence (Nice) said the drug was too expensive to recommend for widespread use in the health service.

Hayley Kalinins, from Borrowash, said: "How can they put a price on anybody's life?

"They do need to bring the cost of the drug down - that is obvious to everybody.

"It's been the miracle drug (for me). I've undergone four different types of chemotherapy before starting this drug.

"I've been on this drug for 18 weeks and experienced very minimal side effects from it, enabling me to have good family times with the four children."

More top news